These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25905033)

  • 1. HIV-1 matrix domain removal ameliorates virus assembly and processing defects incurred by positive nucleocapsid charge elimination.
    Ko LJ; Yu FH; Huang KJ; Wang CT
    FEBS Open Bio; 2015; 5():283-91. PubMed ID: 25905033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.
    Ott DE; Coren LV; Gagliardi TD
    J Virol; 2005 Nov; 79(22):13839-47. PubMed ID: 16254319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.
    Mattei S; Flemming A; Anders-Össwein M; Kräusslich HG; Briggs JA; Müller B
    J Virol; 2015 Oct; 89(19):9739-47. PubMed ID: 26178992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic residues in the nucleocapsid domain of Gag are required for interaction of HIV-1 gag with ABCE1 (HP68), a cellular protein important for HIV-1 capsid assembly.
    Lingappa JR; Dooher JE; Newman MA; Kiser PK; Klein KC
    J Biol Chem; 2006 Feb; 281(7):3773-84. PubMed ID: 16275648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and Dependent on the Spacer Peptide Assembly Domain.
    Dick RA; Barros M; Jin D; Lösche M; Vogt VM
    J Virol; 2015 Dec; 90(5):2473-85. PubMed ID: 26676779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly and release of human immunodeficiency virus type 1 Gag proteins containing tandem repeats of the matrix protein coding sequences in the matrix domain.
    Wang CT; Chen SS; Chiang CC
    Virology; 2000 Dec; 278(1):289-98. PubMed ID: 11112503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the nucleocapsid region in HIV-1 Gag assembly as investigated by quantitative fluorescence-based microscopy.
    de Rocquigny H; El Meshri SE; Richert L; Didier P; Darlix JL; Mély Y
    Virus Res; 2014 Nov; 193():78-88. PubMed ID: 25016037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIV-1 nucleocapsid protein recruits negatively charged lipids to ensure its optimal binding to lipid membranes.
    Kempf N; Postupalenko V; Bora S; Didier P; Arntz Y; de Rocquigny H; Mély Y
    J Virol; 2015 Feb; 89(3):1756-67. PubMed ID: 25410868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between HIV-1 Gag Multimerization and Membrane Binding.
    Sumner C; Ono A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 matrix protein repositioning in nucleocapsid region fails to confer virus-like particle assembly.
    Chang CY; Chang YF; Wang SM; Tseng YT; Huang KJ; Wang CT
    Virology; 2008 Aug; 378(1):97-104. PubMed ID: 18550141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 3-O-(3',3'-dimethylsuccinyl) derivative of betulinic acid (DSB) inhibits the assembly of virus-like particles in HIV-1 Gag precursor-expressing cells.
    DaFonseca S; Blommaert A; Coric P; Hong SS; Bouaziz S; Boulanger P
    Antivir Ther; 2007; 12(8):1185-203. PubMed ID: 18240859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in capsid major homology region affect assembly and membrane affinity of HIV-1 Gag.
    Chang YF; Wang SM; Huang KJ; Wang CT
    J Mol Biol; 2007 Jul; 370(3):585-97. PubMed ID: 17532005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine leukemia virus Gag particle assembly in insect cells: formation of chimeric particles by domain-switched leukemia/lentivirus Gag polyprotein.
    Kakker NK; Mikhailov MV; Nermut MV; Burny A; Roy P
    Virology; 1999 Dec; 265(2):308-18. PubMed ID: 10600602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the self-interaction domains in the simian immunodeficiency virus Gag polyprotein.
    Rauddi ML; Mac Donald CL; Affranchino JL; González SA
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):303-16. PubMed ID: 20969459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.
    Shehu-Xhilaga M; Kraeusslich HG; Pettit S; Swanstrom R; Lee JY; Marshall JA; Crowe SM; Mak J
    J Virol; 2001 Oct; 75(19):9156-64. PubMed ID: 11533179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.
    Pachulska-Wieczorek K; Błaszczyk L; Biesiada M; Adamiak RW; Purzycka KJ
    Retrovirology; 2016 Mar; 13():18. PubMed ID: 26987314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio.
    Haraguchi H; Sudo S; Noda T; Momose F; Kawaoka Y; Morikawa Y
    Microbiol Immunol; 2010 Dec; 54(12):734-46. PubMed ID: 21091985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.
    Yovandich JL; Chertova EN; Kane BP; Gagliardi TD; Bess JW; Sowder RC; Henderson LE; Gorelick RJ
    J Virol; 2001 Jan; 75(1):115-24. PubMed ID: 11119580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro processing of human immunodeficiency virus type 1 Gag virus-like particles.
    Morikawa Y; Shibuya M; Goto T; Sano K
    Virology; 2000 Jul; 272(2):366-74. PubMed ID: 10873780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.